Discussion This single-center open-labeled randomized clinical trial aimed at clearing the clinical equipoise raised by the results of the ISAR TEST 3 trial which showed a trend to higher MACEs at the end of 1 year in the PF group. 10 The difference was mainly because of the higher TLR in the PF group, and the decision to perform an angiogram was not based on clinical end points.
← all excerpts
Open-labeled randomized controlled trial to evaluate the 1-year clinical outcomes of polymer-free sirolimus-eluting coronary stents as compared with biodegradable polymer-based sirolimus-eluting coronary stents.
1
—
—